These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33377009)

  • 1. CRISPR-Cas9 Ribonucleoprotein-Mediated Genomic Editing in Primary Innate Immune Cells.
    Hildreth AD; Riggan L; O'Sullivan TE
    STAR Protoc; 2020 Dec; 1(3):100113. PubMed ID: 33377009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR-Cas9 Ribonucleoprotein-Mediated Genomic Editing in Mature Primary Innate Immune Cells.
    Riggan L; Hildreth AD; Rolot M; Wong YY; Satyadi W; Sun R; Huerta C; O'Sullivan TE
    Cell Rep; 2020 May; 31(7):107651. PubMed ID: 32433960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized electroporation of CRISPR-Cas9/gRNA ribonucleoprotein complex for selection-free homologous recombination in human pluripotent stem cells.
    Xu H; Kita Y; Bang U; Gee P; Hotta A
    STAR Protoc; 2021 Dec; 2(4):100965. PubMed ID: 34825222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protocol for the electroporation of CRISPR-Cas for DNA and RNA targeting in Bos taurus zygotes.
    Biase FH; Schettini G
    STAR Protoc; 2024 Mar; 5(1):102940. PubMed ID: 38460133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR/Cas9 Ribonucleoprotein-mediated Precise Gene Editing by Tube Electroporation.
    Ma L; Jang L; Chen J; Song J; Yang D; Zhang J; Chen YE; Xu J
    J Vis Exp; 2019 Jun; (148):. PubMed ID: 31282887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electroporation-Mediated Delivery of Cas9 Ribonucleoproteins Results in High Levels of Gene Editing in Primary Hepatocytes.
    Rathbone T; Ates I; Fernando L; Addlestone E; Lee CM; Richards VP; Cottle RN
    CRISPR J; 2022 Jun; 5(3):397-409. PubMed ID: 35238624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene Editing in Green Alga Chlamydomonas reinhardtii via CRISPR-Cas9 Ribonucleoproteins.
    Kelterborn S; Boehning F; Sizova I; Baidukova O; Evers H; Hegemann P
    Methods Mol Biol; 2022; 2379():45-65. PubMed ID: 35188655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR-Cas9-Based Genome Editing and Cytidine Base Editing in
    Wang Y; Wang Z; Ji Q
    STAR Protoc; 2020 Jun; 1(1):100025. PubMed ID: 33111078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome editing in
    Sinha T; Yazdani SS
    STAR Protoc; 2022 Sep; 3(3):101629. PubMed ID: 36042883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimized protocol to create deletion in adherent cell lines using CRISPR/Cas9 system.
    Farooq U; Notani D
    STAR Protoc; 2021 Dec; 2(4):100857. PubMed ID: 34746853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiplexed CRISPR-Cas9 protocol for large transgene integration into the Schistosoma mansoni genome.
    Ittiprasert W; Moescheid MM; Mann VH; Brindley PJ
    STAR Protoc; 2024 Mar; 5(1):102886. PubMed ID: 38354082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR-Cas12a ribonucleoprotein-mediated gene editing in the plant pathogenic fungus
    Huang J; Cook DE
    STAR Protoc; 2022 Mar; 3(1):101072. PubMed ID: 35005648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipofection-Based Delivery of CRISPR/Cas9 Ribonucleoprotein for Gene Editing in Male Germline Stem Cells.
    Obermeier M; Rogiers V; Vanhaecke T; Baert Y
    Methods Mol Biol; 2024; 2770():123-134. PubMed ID: 38351451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical Control of a CRISPR/Cas9 System for Gene Editing by Using Photolabile crRNA.
    Zhang Y; Ling X; Su X; Zhang S; Wang J; Zhang P; Feng W; Zhu YY; Liu T; Tang X
    Angew Chem Int Ed Engl; 2020 Nov; 59(47):20895-20899. PubMed ID: 33448579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly Efficient CRISPR-Associated Protein 9 Ribonucleoprotein-Based Genome Editing in
    Nomura T; Yoshikawa M; Suzuki K; Mochida K
    STAR Protoc; 2020 Jun; 1(1):100023. PubMed ID: 33111076
    [No Abstract]   [Full Text] [Related]  

  • 16. Protocol for genomic editing in human resting primary NK cells and NK-92 cells via CRISPR-Cas9 ribonucleoproteins.
    Verhezen T; Lau HW; Van Audenaerde J; Wouters A; Smits E; De Waele J
    STAR Protoc; 2024 Sep; 5(3):103123. PubMed ID: 38935511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomimetic Mineralization-Based CRISPR/Cas9 Ribonucleoprotein Nanoparticles for Gene Editing.
    Li S; Song Z; Liu C; Chen XL; Han H
    ACS Appl Mater Interfaces; 2019 Dec; 11(51):47762-47770. PubMed ID: 31773942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas9-mediated knockout of clinically relevant alloantigenes in human primary T cells.
    Kamali E; Rahbarizadeh F; Hojati Z; Frödin M
    BMC Biotechnol; 2021 Jan; 21(1):9. PubMed ID: 33514392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome Editing in Chlamydomonas reinhardtii Using Cas9-gRNA Ribonucleoprotein Complex: A Step-by-Step Guide.
    Dhokane D; Kancharla N; Savarimuthu A; Bhadra B; Bandyopadhyay A; Dasgupta S
    Methods Mol Biol; 2023; 2653():207-217. PubMed ID: 36995629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electroporation-Mediated CRISPR/Cas9 Genome Editing in Rat Zygotes.
    Davis DJ; Men H; Bryda EC
    Methods Mol Biol; 2023; 2631():267-276. PubMed ID: 36995672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.